IN-DATE
200-150: LivaNova MICS RAP Femoral Venous Cannula 23/25F x 65.5cm
Sign in to add this product to your favorites!
| Price: | $416.50 EACH |
|---|---|
| Quantity: | |
| In Stock: | 5 eaches |
| Expiration: | 09-2027 |
Additional Details
LivaNova MICS Cannulae RAP Femoral Venous
Livanova RAP Femoral Venous Cannulae are designed for improved venous drainage, with a dual stage tip which drains from superior and inferior vena cava. Available in two sizes with full-flow drainage capability. A high-quality soft introducer features a smooth transition of the cannula to improve insertion and reduce vascular damage.
AccessGUDID Info
- FDA Product Code: DWF
- FDA Product Code Name: CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS
- GMDN Term Code: 47733
- GMDN Term Name: Cardiopulmonary bypass cannula, femoral
- GMDN Term Description: A sterile, rigid or semi-rigid tube designed to be inserted into a femoral artery or vein during cardiopulmonary bypass procedures. It is typically a 9 to 24 Fr tube with an end hole (some may include side holes); it is short enough to keep the distal tip inside the femoral vessel. The tube is used in set-ups/systems intended to divert the patient's blood to and from external tubing and an arterial pump, bypassing the heart and lungs completely. This is a single-use device.
Manufacturer
LivaNova PLC is a global leader in medical technology, specializing in innovative solutions for cardiac surgery, neuromodulation, and cardiopulmonary support. Headquartered in London, England, and with operations worldwide, LivaNova combines decades of expertise with cutting-edge research to develop life-changing devices and therapies. Its diverse portfolio includes advanced systems for heart-lung machines, implantable neuromodulation devices for epilepsy and depression, and solutions for managing heart valve and coronary conditions. Renowned for its commitment to improving patient outcomes and enhancing quality of life, LivaNova collaborates closely with healthcare professionals to drive innovation and deliver exceptional care in the treatment of complex conditions.
